Danish healthcare company Novo Nordisk has dropped prices for its weight-loss and diabetes drug Wegoy, the injectable ...

The announcement comes as the Danish drugmaker struggles to grab significant market share in the Indian market before it ...

Danish drugmaker Novo Nordisk on Tuesday announced slashing prices of its weight-loss drug Wegovy by up to 37 per cent in a ...

The president’s agreement with drug companies involves a range of prices, depending on dose, product and how you’re paying.

Danish drugmaker Novo Nordisk has teamed up with Emcure Pharmaceuticals to increase access to its weight-loss drug ...

Novo Nordisk A/S (NYSE:NVO) on Tuesday announced that it has submitted an application to the European Medicines Agency (EMA) for approval of a new, higher dose of its obesity treatment, Wegovy ...

With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the ...

Novo Nordisk India reduces the price of its obesity medication Wegovy by 37%. Starting dose now available at Rs 2,712 per week.

Novo Nordisk has partnered with Emcure Pharma to distribute and market its diabetes and weight loss injection semaglutide ...

Emcure Pharma will be the exclusive distributor responsible for the commercialisation and marketing of Poviztra, the second brand of Wegovy.

The company announced that the starting dose of Wegovy (0.25 mg) will now cost Rs 2,712 per week, down from Rs.4,336 ...